BioRegenx, Inc.
BRGX
$0.01
-$0.0039-28.06%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -178.30K | -266.90K | -18.40M | -394.90K | -1.11M |
| Total Depreciation and Amortization | 37.40K | 12.40K | 574.50K | 574.50K | 569.70K |
| Total Amortization of Deferred Charges | -1.20K | 1.50K | 14.30K | 8.60K | 13.60K |
| Total Other Non-Cash Items | 94.40K | 91.30K | 17.66M | -260.50K | 240.70K |
| Change in Net Operating Assets | 50.90K | 199.30K | 139.60K | 41.10K | 104.80K |
| Cash from Operations | 3.20K | 37.70K | -11.40K | -31.20K | -177.30K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.00K | -- | 2.70K | 0.00 | 0.00 |
| Cash from Investing | -50.00K | -- | 2.70K | 0.00 | 0.00 |
| Total Debt Issued | 30.00K | -- | 1.50K | 56.80K | 132.10K |
| Total Debt Repaid | -13.20K | -10.40K | -8.50K | -10.30K | -12.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.80K | -10.40K | -6.90K | 46.40K | 120.10K |
| Foreign Exchange rate Adjustments | -7.20K | -2.10K | 4.00K | -2.60K | 500.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.20K | 25.20K | -11.70K | 12.70K | -56.80K |